Stock RLFTY RELIEF THERAPEUTICS HOLDING SA
Add to a list
To use this feature you must be a member
Log inSign up

News Relief Therapeutics Holding SA OTC Markets

Equities

RLFTY

US7595JP3044

Market Closed - OTC Markets
Other stock markets
 16:57:35 08/05/2024 BST 		5-day change 1st Jan Change
1.365 USD -2.54% Intraday chart for Relief Therapeutics Holding SA -2.54% -35.00%
05-08 Relief Therapeutics Restructures Management Team, Creates New Roles MT
05-08 Relief Therapeutics Announces Executive Changes CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Relief Therapeutics Restructures Management Team, Creates New Roles
MT
Relief Therapeutics Announces Executive Changes
CI
Relief Therapeutics Holding SA Announces Chief Financial Officer Changes
CI
Relief Therapeutics Holding SA Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Relief Therapeutics' FY23 Loss Widens; Revenue Edges Down
MT
RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting
AQ
Sector Update: Health Care Stocks Steady Pre-Bell Friday
MT
Sector Update: Health Care
MT
Eton Pharmaceuticals Acquires US Rights to Phenylketonuria Dietary Management Product
MT
Relief Therapeutics Grants Eton Pharmaceuticals Exclusive License for US Commercialization of Golike
MT
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE
CI
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
AQ
Relief Therapeutics Extends CHF50 Million Share Subscription Facility with Largest Shareholder
MT
Relief Therapeutics Holding SA announced that it expects to receive CHF 50 million in funding from Global Emerging Markets and another investor
CI
Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth
AQ
Relief Therapeutics to Run Commercial Operations Via Partnership Model
MT
Relief Therapeutics Announces CEO Transition
AQ
Relief Therapeutics CEO to Leave; Interim Successor Takes Over
MT
Relief Therapeutics Holding Sa Announces CEO Changes
CI
Relief Therapeutics announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RLF Stock
  4. RLFTY Stock
  5. News Relief Therapeutics Holding SA